Connection

Arunaloke Chakrabarti to Antifungal Agents

Back to Details
This is a "connection" page, showing publications Arunaloke Chakrabarti has written about Antifungal Agents.
Arunaloke Chakrabarti
Connection Strength
4.178
Antifungal Agents
  1. In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. J Antimicrob Chemother. 2019 10 01; 74(10):2943-2949.
    View in: PubMed
    Score: 0.370
  2. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018 09; 52(3).
    View in: PubMed
    Score: 0.345
  3. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species. J Med Microbiol. 2018 Jul; 67(7):922-926.
    View in: PubMed
    Score: 0.337
  4. Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance. Antimicrob Agents Chemother. 2018 05; 62(5).
    View in: PubMed
    Score: 0.335
  5. A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma. Chest. 2018 03; 153(3):656-664.
    View in: PubMed
    Score: 0.329
  6. Histoplasmosis in non-endemic North-Western part of India. Indian J Med Microbiol. 2018 Jan-Mar; 36(1):61-64.
    View in: PubMed
    Score: 0.328
  7. Cladophialophora bantiana brain abscess: A report of two cases treated with voriconazole. Indian J Med Microbiol. 2017 Oct-Dec; 35(4):620-622.
    View in: PubMed
    Score: 0.322
  8. Multidrug-resistant Candida auris: Need for alert among microbiologists. Indian J Med Microbiol. 2017 Jul-Sep; 35(3):436.
    View in: PubMed
    Score: 0.317
  9. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021 Sep; 64(9):1028-1037.
    View in: PubMed
    Score: 0.105
  10. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 06; 21(6):e149-e162.
    View in: PubMed
    Score: 0.101
  11. Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India. Med Mycol. 2020 Jun 01; 58(4):425-433.
    View in: PubMed
    Score: 0.097
  12. Biofilm formation by Candida auris isolated from colonising sites and candidemia cases. Mycoses. 2019 Aug; 62(8):706-709.
    View in: PubMed
    Score: 0.091
  13. A Rhinofacial Conidiobolus coronatus Fungal Infection Presenting as an Intranasal Tumour. Sultan Qaboos Univ Med J. 2018 Nov; 18(4):e549-e552.
    View in: PubMed
    Score: 0.089
  14. Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps. Antimicrob Agents Chemother. 2018 11; 62(11).
    View in: PubMed
    Score: 0.087
  15. Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India. Emerg Infect Dis. 2018 10; 24(10):1956-1958.
    View in: PubMed
    Score: 0.086
  16. Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis. Mycopathologia. 2019 Feb; 184(1):151-154.
    View in: PubMed
    Score: 0.086
  17. Gastrointestinal mucormycosis in apparently immunocompetent hosts-A review. Mycoses. 2018 Dec; 61(12):898-908.
    View in: PubMed
    Score: 0.085
  18. Calcium Alginate Bead-mediated Enhancement of the Selective Recovery of a Lead Novel Antifungal Bacillomycin Variant. Appl Biochem Biotechnol. 2018 Dec; 186(4):917-936.
    View in: PubMed
    Score: 0.084
  19. Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS. Med Mycol. 2018 Feb 01; 56(2):234-241.
    View in: PubMed
    Score: 0.083
  20. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1. Antimicrob Agents Chemother. 2018 01; 62(1).
    View in: PubMed
    Score: 0.082
  21. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017 11; 17(11):e357-e366.
    View in: PubMed
    Score: 0.080
  22. Mucormycosis at a tertiary care centre in Gujarat, India. Mycoses. 2017 Jun; 60(6):407-411.
    View in: PubMed
    Score: 0.078
  23. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017 Sep; 43(9):1225-1238.
    View in: PubMed
    Score: 0.077
  24. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses. 2017 Jun; 60(6):375-380.
    View in: PubMed
    Score: 0.077
  25. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 2021 Sep; 64(9):1015-1027.
    View in: PubMed
    Score: 0.026
  26. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis. 2021 Sep; 27(9):2349-2359.
    View in: PubMed
    Score: 0.026
  27. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2019 03; 39(3):503-513.
    View in: PubMed
    Score: 0.022
  28. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017 06 01; 72(6):1794-1801.
    View in: PubMed
    Score: 0.020
  29. Non-healing ulcer due to Trichosporon loubieri in an immunocompetent host and review of published reports. Mycopathologia. 2013 Aug; 176(1-2):107-11.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.